Objective To compare the performance of different types of detectors in breast cancer detection. Methods A mammography image set containing subtle malignant non-calcification lesions, biopsy-proven benign lesions, simulated malignant calcification clusters and normals was acquired using amorphous-selenium (a-Se) detectors. The images were adapted to simulate four types of detectors at the same radiation dose: digital radiography (DR) detectors with a-Se and caesium iodide (CsI) convertors, and computed radiography (CR) detectors with a powder phosphor (PIP) and a needle phosphor (NIP). Seven observers marked suspicious and benign lesions. Analysis was undertaken using jackknife alternative free-response receiver operating characteristics weighted figure of merit (FoM). The cancer detection fraction (CDF) was estimated for a representative image set from screening.
Introduction
Prospective [1, 2] and retrospective reviews [3] [4] [5] [6] [7] [8] [9] [10] of screening studies have been undertaken to compare the clinical performance of digital imaging systems and screen film mammography (SFM). The switch from SFM is now permanent, but only a few retrospective screening review studies have compared cancer detection performance with different digital detectors [6] [7] [8] [9] [10] . There are a number of different digital detectors for mammography on the market, and these have a wide range of image qualities, as measured by physical metrics [11] . Two retrospective studies [9, 10] demonstrated that the cancer detection rate using powder image plate (PIP) computed radiography (CR) was lower than with digital radiography (DR) systems. In particular, there were large differences in the detection of in situ cancers. A third retrospective study [8] claimed comparable detection rates for CR PIP with DR, but at a cost of 60 % higher mean glandular dose (MGD) for CR. To date, no clinical studies have reported on the effect on cancer detection of using the potentially better needle image plate (NIP) CR technology.
Judging the effect of using different types of imaging detectors on cancer detection from retrospective reviews of data from breast cancer screening programmes is difficult, because of the large number of confounding factors. These include differences in women, radiologists, X-ray equipment, dose and radiographic practice. Prospective studies might be better, but would still have many confounding factors and take years to complete because of the low prevalence of breast cancer in screening.
A faster clinical evaluation method for digital mammography detectors with fewer confounding factors is required. To address this, the present work comprises an observer study based on a method [12] to adapt one set of mammograms to appear with the image quality of a range of detectors: DR detectors with amorphous-selenium (a-Se) and caesium iodide (CsI) convertors, and CR detectors with PIP and NIP phosphors. This study builds on a previous study of this type [13] with improved simulation, use of both breasts, wider range of cancer types and improved reporting software, with the purpose of comparing the performance of different types of detectors in the detection of breast cancers.
Materials and methods
The study protocol was approved by the regional research ethics committee. Individual consent was not required as the study used anonymous mammographic images and data.
Image selection
Mammograms were collected from one screening centre [14] , where women between the ages of 50 and 70 years old are invited for mammography screening triennially. During screening, both breasts are imaged using mediolateral oblique (MLO) and craniocaudal (CC) views. The centre has five Hologic Selenia and two Hologic Dimensions X-ray units (Hologic inc., Bedford, USA). From March 2011, all available mammograms with a malignancy and a random selection of biopsy-proven benign lesions and normals were collected to create a database. An expert radiologist, who did not participate in the study, marked a region of interest (ROI) around the cancers and benign lesions in the database and classified their appearance (mass, distortion, focal asymmetry, calcification clusters) and conspicuity (very subtle, subtle, or obvious) in each view. The images used in this study were acquired between April 2011 and December 2012. The cases and images were chosen as follows:
Normal images: The database contained 580 cases that had been classified as not requiring further investigation. Eighty cases were randomly selected from the database and classified as normals. Insertion of calcification clusters into images: Eightynine malignant calcification clusters were inserted into a further 80 pairs of normal images randomly selected from the database. There was a maximum of three clusters inserted per case. The original clusters were extracted from images of mastectomy slices acquired at high magnification in a specimen cabinet. The process of extraction and insertion of calcification clusters has been validated such that the calcifications matched real malignant clusters in image quality and appearance [15, 16] . The locations for the insertions were chosen to ensure that the calcifications were seen in a wide range of glandularities. The expert radiologist visually reviewed the final images for realism of the location and appearance of the calcification clusters. Images containing malignant lesions (non-calcification): Eighty pairs of images were selected from the database containing 459 cases with marked non-calcification lesions. Each selected case contained at least one biopsyproven malignant lesion that was described as subtle or very subtle in the view chosen. Ideally, simulated lesions would have been used to remove any selection bias.
However, the full range of these types of lesions cannot be accurately simulated. Images containing biopsy-proven benign lesions: Twenty-nine pairs of images with biopsy-proven benign lesions were added to the image set.
In total, 269 cases were used in this study. For each selected case, one view (either CC or MLO) of both breasts was randomly selected for the study. For 44 of the non-calcification cases, only one view met the subtlety criterion and was selected. Only one view from each case was used in this study, as realistic insertion of calcifications into two views was not possible.
Due to time constraints, the study was started before the women whose images had been used in the study had returned for their 3-year breast screen examination. Therefore, the cases had not been confirmed as cancer free. Subsequently, 134 out of the 160 women classified as not having cancer and 21 out of the 29 women with a biopsy-proven benign lesion returned for routine screening. Two cases used as normals and one case used for insertion of calcification clusters were found to have a cancer at the subsequent screening. These three cases were removed from the analysis.
Image conversion
A validated methodology [12, 17] was used to adjust the 'for processing' images to appear as if they had been acquired using four detector types: a-Se photoconductor, CsI phosphor, CR NIP and CR PIP detectors ( Table 1) .
The simulation methodology adjusts the sharpness of the image using measured modulation transfer functions. Extra noise is added to the images to match the required image quality. The extra noise is calculated from noise power spectra measurements, taking into account the pixel values in the unprocessed image, since this is related to the energy absorbed in the detector at that point. Other factors that are also included are the tube voltage, anode/filter combination and compressed breast thickness. The pixel pitch in the simulated images is the same as the original images, corresponding to a detector pixel pitch of 70 μm. The final image quality is representative of the type of detector being simulated, rather than being an exact match for a specific detector. The characterization of the image quality of these study arms is published elsewhere [18] . To be able to adjust the images to simulate the CsI Arm, it was necessary during simulation to apply a dose reduction of 20 % to all images. The MGD for the original images for breast thickness between 50 and 60 mm was 1.36 mGy [19] , which was reduced to 1.08 mGy for all arms of the study, which is still within the range of clinical doses [20] . The images in the study were post-processed using 'MUSICA 2 ' (Agfa Healthcare NV, Mortsel, Belgium) image processing. This software is designed to work for a variety of detectors and dose levels, and was suitable for each study arm without any software adjustments. Figures 1 and 2 show examples of the appearance of non-calcification lesions and calcification clusters in the four study arms.
Observer study
Seven observers were recruited from two hospitals. Each observer was an accredited reader working in the NHS breast screening programme with between 3 and 21 years' experience and reading over 3,500 screening mammography cases annually.
Images were reviewed on mammography workstations equipped with two 5-megapixel monitors: Barco MDMG (Barco NV, Kontrijk, Belgium) at one hospital and Eizo Radiforce GS520 monitors (Eizo, Ishikawa, Japan) at the other hospital. Each case was shown to the readers using MedXviewer software [21] in the following order: 1) Both images were displayed de-magnified to fit on one monitor; 2) The images were then scaled to fit one per monitor; 3) The images were shown in quadrant zoom at magnification 1.2. Panning the image and use of a magnification tool were the only controls available to the observers, as in clinical practice other tools are not commonly used.
To reduce bias due to learning effects, each observer viewed the images in a different order with a minimum interval of 14 days before seeing the same case again at a different image quality. The observers were not informed of the underlying purpose of the study, nor of the prevalence of cancers or number of lesions per case. The observers were asked to mark any suspicious or benign lesions. The locations of the marks and the responses were automatically recorded. The following question was posed for each lesion marked: Indicate whether you would recall this patient on the basis of this lesion, along with your confidence in this decision, i.e. your confidence that a recalled lesion will be malignant. 
Data analysis of observer study
A mark was considered a lesion localisation if it was within the ROI of the malignant lesion defined by the expert radiologist. Marks outside of the ROIs or within the ROI of a benign lesion were classed as non-lesion localisations. The data were analysed using JAFROC-4.2 software (www.devchakraborty. com) [22] . The analysis was performed for random observers and random cases, i.e. the observers and cases were assumed to be random samples from their respective populations. As part of the jackknife alternative free-response receiver operating curves (JAFROC) analysis, a global F test using the null hypothesis that all the arms are equal was undertaken. Observer performance was characterised by the equally weighted JAFROC figure of merit (FoM). Significance testing was performed using Dorfman-Berbaum-Metz analysis of variance [23] .
The study question splits between recall (rating≥4) and not recall (rating≤3), and provides a natural operating point for investigating the correctly or incorrectly recalled cancers. The false recall fraction (FRF) was calculated as the fraction of cases (without cancers) with at least one non-lesion localisation mark with a rating of 4 or greater. The cancer detection fraction (CDF) was calculated as the fraction of cancers with a lesion localisation mark with a rating of 4 or greater.
The cancer images in this study are a selected subset from the database of screen-detected cancers. It is of interest to generalise the study results to the whole image database by estimating the CDF db , if the study had been undertaken using all cases in the image database. The CDF db was estimated using the measured CDFs, the proportion of calcification clusters and non-calcification lesions in the database and an estimate of the CDF for the types of cancers not represented in the Warren et al. [16] showed that the inserted calcification clusters were representative of approximately 60 % of calcification clusters seen in the image database. The non-calcification cancers used in the study were judged to be equivalent to 26 % (241/925) of non-calcifications cancers in the database on the basis of conspicuity grading (i.e. subtle or very subtle in both views). The CDF for the lesions in the database not represented in this study (40 % of calcification clusters and 74 % of non-calcifications) were estimated using the alternate assumptions that they are all detected irrespective of the image quality or at the same rate as in the study. A range in the CDF db was then estimated using the above information.
Results

Observer study
The results of the global F test gave F values equal to 18.1 [degrees of freedom (DF) of 3 and 46] and 7.4 (DF of 3 and 43) for the calcification clusters and noncalcification lesions, respectively. Therefore, there are significant differences between the study arms for both calcification clusters (p<0.0001) and non-calcification lesions (p=0.0004). Figure 3a and b show the alternative free-response receiver operating characteristics (AFROC) curves for the marking and scoring of calcification clusters and non-calcification lesions, and Fig. 3c and d show their corresponding JAFROC FoM. The percentage differences between the JAFROC FoMs are shown in Table 2 . For the calcification clusters, there were significant differences between each of the arms except between the a-Se and CsI arms. For the non-calcification lesions, the only significant differences were between the DR and the CR detectors.
The FRF for all marks and the CDF for calcification clusters and non-calcification lesions for each arm are shown in Figs. 4 and 5, respectively. The DR arm was created by averaging the results of the a-Se and CsI arms, as there was no significant difference between these arms. The percentage differences for the two CR arms compared to the DR arms for FRF and CDF are shown in Tables 3 and 4 , respectively. The FRF for the CR PIP detector was significantly lower than that for either DR detector, while there was no significant difference in the FRF for the CR NIP detector compared to the DR detectors. Table 4 shows that the fraction of cancers detected was significantly lower for CR technologies compared to DR technologies, except between a-Se and CR NIP arms for noncalcification lesions. The CDFs of calcification clusters were more affected by detector type than the non-calcification lesions. Table 4 also shows the estimated effect on CDF db for a representative set of screening images for CR PIP and CR NIP compared to DR. The maximum estimated differences in cancer detection in screening were 15 % and 22 % lower for CR NIP and CR PIP, respectively, compared to DR at the same dose. The CDF db for CR NIP was up to 11 % higher than for CR PIP (Table 5) , which was almost entirely due to differences in detection of calcification clusters.
Discussion
This study examined types of detectors that are used internationally in breast screening programs. We have found significant differences between the detectors for the detection of both calcification clusters and non-calcification lesions without a change in dose. Overall, the DR detectors perform significantly better than CR NIP, which in turn is significantly better than CR PIP.
The estimated CDF for CR PIP was estimated to be between 10 % and 22 % lower than for DR for a representative set of screening images. It is impractical to run an observer study that exactly matches screening, but there is evidence that the performance of experienced mammography readers in observer studies correlates with their performance in screening [24] . Two retrospective screening studies [9, 10] calculated the cancer detection rate (CDR) for two detector types: DR (equivalent to combination of a-Se and CsI arms) and CR PIP. They showed that the cancer detection rate for using CR PIP was 31 % [9] and 23 % [10] lower than for using DR detectors. The upper estimate of the measurements for the CR PIP arm is lower than these results, but it does provide evidence that the major cause of reduced cancer detection for CR PIP was due to the detector type used. Some large differences in cancer detection were seen in retrospective screening studies [8] [9] [10] , although they were not always significant. Our study was more sensitive and significant differences were measured by using a set of subtle cancers and by avoiding differences between the patient samples that occurred in other studies. The effect of using CR NIP detectors in breast screening has not been published previously. Our study provides evidence that the CDR of CR NIP is expected to be better than that for CR PIP, but less than for DR without a change in MGD for each detector. Our study examines cancer detection and does not investigate whether there is a clinical benefit to the higher cancer detection rate associated with DR systems. However, Weigel et al. [25] have shown that where there were variations in overall cancer detection rates in screening, this was due to differences in all types of cancers and not just in low risk groups. This suggests that high cancer detection in screening is beneficial. Warren et al. [13] have previously shown a relationship between calcification detection and image quality, as measured using the CDMAM contrast detail test object as described in European Guidelines [26] . This is expected, as the detection of the details in the phantom and calcifications are affected by noise associated with the detector. The non-calcification lesions are much larger than individual calcifications, and detection of these lesions is likely to be affected more by anatomical structure than by the noise associated with the detector, and so a strong relationship with standard quality assurance test objects is not expected [27, 28] .
Although the study was designed to examine cancer detection, it was of interest to study the FRF. The FRF was high due to the decreased specificity of readers in observer studies [29] and as 27 % [29/107) of the cases without cancers contained a biopsy-proven benign lesion. The FRF for CR PIP was significantly lower than for other detectors. It is likely that the relatively poor image quality for CR PIP reduced the visibility of suspicious areas, rather than aiding the observer to distinguish between malignant and benign lesions.
In this study, there was no difference in the doses between the study arms. A previous study [13] showed that the detection of calcification clusters is sensitive not only to the detector type, but also to dose. Therefore, it is expected that increasing the MGD will increase calcification detection. Table 6 shows the difference in dose between the DR and CR PIP imaging systems in the literature [8] [9] [10] . The results in the table indicate that dose for CR PIP should be at least 60 % higher than for DR. Even at higher dose, the detection of in-situ cancers was 27 % lower compared to DR [8] . The data from Warren et al. [13] suggest that the dose should be more than doubled when using CR PIP compared to when using an a-Se detector for calcification detection. It is expected that a smaller dose increase would be required for CR NIP for equivalent cancer detection with DR detectors. The evidence shows that CR must be used at higher doses than DR, but it was not the aim of this study to estimate an appropriate dose.
Our study was different from clinical practice as only one view was used, no previous images were available and the image set was enriched with cancers. There were many cancers marked that did not appear sufficiently suspicious for the observers to classify them for recall. The use of a second view could have increased the number of cancers correctly recalled and reduced the number of false positives. Image processing must be used to ensure that the image quality is adequate for reporting. 'MUSICA 2 ' processing was used for all study arms, as it is flexible and as an attempt to reduce differences between the arms in this study not due to the detector. Other manufacturers have their own specific processing, which may affect cancer detection. There is a potential for selection bias in this study, as all of the original non-calcification lesions were found during screening using Hologic imaging systems. However, the bias may be reduced as the appearance of the a-Se arm images were changed from that originally seen during screening, due to a change in dose and image processing. Also, many of these lesions would have been primarily identified using the other view where the lesion was classified with a conspicuity of 'obvious'. The calcifications clusters do not have a selection bias. A study weakness is that the radiographic factors are the same for the simulated images as for the original images, which may not be optimal for other detectors. The image quality levels used were for well set-up equipment, and so this study does not account for deterioration and artefacts that may occur. For example, more technically inadequate mammograms were found using CR PIP compared to DR or SFM [10] and distracting dust artefacts were noted in CR PIP [11] . Ultimately, it must be realised that the study arms are representative of detectors types rather than specific detectors. Also, the X-ray system, radiographic factors and image processing used with the detector will also influence cancer detection.
The study compared the differences in performance between detector types using one set of clinical images and a clinically relevant question, while confounding factors such as differences in women, readers, X-ray systems, post- processing and anti-scatter grid were removed. We have shown significant differences in the detection of lesions between detector types when the same dose was used. The detector type and its potential effect on cancer detection must be considered during the procurement process for systems. The use and set up of CR imaging systems in mammography should be reconsidered.
